Clinically, adiponectin is used as a biomarker in obesity-related diseases, and its level showed an inverse relationship with increasing central adiposity and type 2 diabetes [24,25]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.